ESCAPE21
Porto
Carras Resort, Chalkidiki –
“Multi-scale models for the design of crystalline solids”
Michael F. Doherty, Zubin B. Kuvadia, Michael A.
Lovette and
ABSTRACT:
Crystalline
organic solids are ubiquitous as either final products or as intermediates in
the specialty chemical, pharmaceutical, and home & personal care
industries. Virtually all small molecular weight drugs are isolated as
crystalline materials, and over 90% of all pharmaceutical products are
formulated in particulate, generally crystalline form. Normally, the
properties of the crystalline solid (especially polymorph and crystal shape)
have a major impact on the functionality of the product as well as the design and
operation of the manufacturing process, and in most cases the two cannot
considered separately.
The
current generation of process models for solution crystallization focus on the
prediction of particle size distribution for populations of spherical particles.
In this modeling environment the growth models are isotropic, and are incapable
of predicting the shapes of faceted crystals.
To
predict crystal shape it is necessary to predict the relative growth rates of
the faces which appear on the crystal surface.
The rate determining step for the growth of crystal faces for many
organic solids is surface integration kinetics of solute molecules. Based on this, we have succeeded in
developing the first ever ab initio mechanistic model for predicting the relative growth rates of non-centrosymmetric organic
molecules of realistic complexity. The
key variables on which the model depends are (1) properties of the solid state,
such as unit cell, space group, intermolecular potentials, charge distribution,
etc, (2) properties of steps and kinks (kink rates that account for
non-isotropic behavior, treatment of unstable edges, modified Boltzmann kink
distribution), and (3) surface free energy at the crystal-solution
interface. The resulting multi-scale
model has been successfully applied to a selection of complex molecular
crystals of interest in pharmaceutical and specialty chemical products. High resolution AFM images of growth spirals
on the faces of paracetamol provide validation of the nanoscopic surface growth
mechanism employed in the model.